Gene Mutation Increases Risk of Recurrent Papillary Thyroid Cancer in Some Patients

- Individuals with advanced papillary thyroid cancer (PTC) that are associated with the BRAFV600E gene mutation have a higher risk of recurrent disease and progression to more advanced, poorly differentiated thyroid cancer, according to data presented today at the 81st Annual Meeting of the American Thyroid Association (ATA).

Read the whole article on Newswise - Scinews

More from Newswise - Scinews